AXGN Q4 2018 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

Q4 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$23M+38.1% YoY

Gross Profit

$20M84.5% margin

Operating Income

-$6M-25.0% margin

Net Income

-$5M-22.3% margin

EPS (Diluted)

$-0.13

QoQ Revenue Growth

+3.4%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$160M

Total Liabilities

$13M

Stockholders' Equity

$147M

Cash & Equivalents

$24M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$23M	$17M	+38.1%
Gross Profit	$20M	$14M	+37.9%
Operating Income	-$6M	-$2M	-224.0%
Net Income	-$5M	-$2M	-109.2%